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ABSTRACT  Yeasts provide an excellent genetically tractable eukaryotic sys-
tem for investigating the function of genes in their biological context, and are 
especially relevant for those conserved genes that cause disease. We study 
the role of btn1, the orthologue of a human gene that underlies an early onset 
neurodegenerative disease (juvenile CLN3 disease, neuronal ceroid 
lipofuscinosis (NCLs) or Batten disease) in the fission yeast Schizosaccharomy-
ces pombe. A global screen for genetic interactions with btn1 highlighted a 
conserved key signalling hub in which multiple components functionally re-
late to this conserved disease gene. This signalling hub includes two major 
mitogen-activated protein kinase (MAPK) cascades, and centers on the Tor 
kinase complexes TORC1 and TORC2. We confirmed that yeast cells modelling 
CLN3 disease exhibit features consistent with dysfunction in the TORC path-
ways, and showed that modulating TORC function leads to a comprehensive 
rescue of defects in this yeast disease model. The same pathways may be 
novel targets in the development of therapies for the NCLs and related dis-
eases. 
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INTRODUCTION 
Yeasts have long been used as model systems to shed light 
on basic eukaryotic cell biology, and can provide a rapid 
and comprehensive route of investigation for genes of un-
known function. This is particularly relevant for those 
genes that are conserved across diverse eukaryotic species 
and which can be presumed to play a fundamental biologi-
cal role. A significant health challenge facing current re-
search and drug development is the increasing incidence of 
age-related neurodegenerative disorders. Elucidating the 
mechanisms that underlie neurodegeneration is complex, 
particularly so in common age-related dementias that may 
have numerous contributing factors. There are, however, 
monogenic inherited neurodegenerative diseases that pre-
sent a simpler alternative for investigation and real oppor-
tunities to determine these basic cellular changes, and 
some of the underlying genes are conserved even in yeasts. 
The genetic tractability of yeasts offers particular ad-
vantages to the challenges of understanding disease mech-
anisms in a relevant biological context and this knowledge 
can inform therapeutic development for such conserved 
genetic diseases.     
The neuronal ceroid lipofuscinoses (NCLs) are such a 
group of monogenic neurodegenerative disorders that 
generally affect children [1].  The most common of these is 
juvenile CLN3 disease [2]. This disease is characterised by 
progressive neuronal atrophy that causes visual failure, 
seizures and a progressive decline in cognitive and motor 
function. This disease is accompanied by cellular features 
characteristic of many neurodegenerative conditions [3, 4] 
that include the dysfunction of core cellular processes, 
such as reduced lysosomal and autophagic clearance [5, 6] 
and mitochondrial abnormalities [7]. Moreover, CLN3 dis-
ease also leads to specific cellular pathologies characteris-
tic of more common dementias. These include the accumu-
lation of lipofuscin [1], as observed in aged neurons [4], 
aberrant amyloid-β processing [5], a feature of Alzheimer’s 
disease [8] and α-synuclein accumulation [9], a feature of 
Parkinson’s disease [10].  
Juvenile CLN3 disease is caused by mutations in a single 
gene (CLN3) [2], whose function  is  unknown  but  which  is  
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FIGURE 1: Synthetic genetic array (SGA) analysis of the genetic interactions of btn1. A schematic of the genes involved in stress responses 
that genetically interact with btn1. Genes in red were identified as negative interactors and those in green as positive. Grey genes are in-
volved in these pathways but were not found to interact with btn1. * CESR refers to ‘core environmental stress response’ genes, a group of 
genes that respond to most environmental stressors as described by Chen et al. (2003) [76]. 
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highly conserved across eukaryotic species [11]. As a con-
sequence, this disease is relatively straightforward to re-
produce in experimental systems and, given its similarity to 
more common dementias, such experimental models are 
ideal paradigms to study the basic cellular changes that 
occur in neurodegenerative diseases. The fission yeast 
Schizosaccharomyces pombe contains a single orthologue 
of CLN3 (btn1) [11]. Work in this yeast has revealed a role 
for btn1 in many cellular processes. Like patient cells, yeast 
lacking btn1 (btn1Δ) have enlarged and less acidic vacuoles 
[12] and further work has supported roles for btn1 in vacu-
olar homeostasis [13]. The ability of btn1 modeling the 
most common CLN3 mutation (a 1 Kb deletion) to rescue 
these vacuolar defects found in the btn1Δ null strain has 
also revealed that this mutant allele retains some function, 
making juvenile CLN3 disease a mutation-specific disease 
rather than the consequence of a complete loss of function 
as originally assumed [14].  
A host of further morphological defects exhibited in the 
btn1Δ strain support additional roles for btn1 in cytokinesis 
[12] and the organisation of cell polarity [15].  Furthermore, 
btn1Δ cells also display cell wall defects [16]. Importantly, 
work in this model has expanded our understanding of the 
disease by revealing that btn1 is involved in two independ-
ent pathways; one pH-dependent and one pH-independent, 
thus providing the first suggestion that Batten disease is 
more than a pH-related lysosome disorder [16]. Indeed, a 
comprehensive metabolomics approach has revealed that 
btn1 is required for the regulation of glycolysis and amino 
acid homeostasis [17]. The involvement of btn1 in numer-
ous, apparently disparate, pathways may be a result of 
alterations at the Golgi apparatus, as the number, mor-
phology, and location of thus organelle are affected by its 
deletion [13]. Lastly, this model has been used successfully 
to model disease mutations in Btn1p, an effort that has 
provided valuable insight into their consequences on pro-
tein trafficking and function. It was found that equivalent 
CLN3 disease mutations in btn1 affect the yeast phenotype 
in a way that can accurately predict the severity of disease, 
further establishing yeast as an accurate disease model 
despite its simplicity. Importantly, the observations report-
ed in the fission yeast model have consistently been con-
firmed in mammalian systems [5, 18, 19]. Unfortunately 
however, despite these insights, the molecular processes 
that underlie cell death in this disease are poorly under-
stood, the function of CLN3 is unknown, and there remains 
a significant need for protective therapeutic targets. 
A particular advantage of yeast model systems is the 
availability of genome-wide techniques. Synthetic genetic 
arrays (SGAs) have proved a particularly powerful means of 
exploring genetic interactions in yeast species [20]. This 
approach highlights genes involved in pathways parallel to, 
or converging with, the query gene. This provides infor-
mation about functional relationships among genes, as 
well as processes that suppress the defects associated with 
a particular mutation. As they are hypothesis-free, SGAs 
are particularly valuable in the investigation of complex 
biological problems and those where gene function is un-
clear. These advantages are particularly relevant for neu-
rodegeneration in general, due to the complexity of the 
problem, and for juvenile CLN3 disease in particular, due to 
the lack of a clear gene function. SGAs have previously 
been employed in budding yeast to investigate mutant 
huntingtin and α-synuclein toxicity [21]. Such an approach 
can place the gene under investigation within its biological 
context and thereby uncover much-needed protective 
pathways for neurodegenerative disease. 
We applied SGA analysis to identify pathways that are 
altered as a consequence of loss of function of btn1 in an 
effort to better understand the molecular consequences of 
CLN3 disease, and to provide new candidate target path-
ways and processes for therapeutic development. A third 
of the genetic interactions that were identified centered on 
a set of conserved and connected signalling pathways. Ma-
nipulation of these pathways leads to a complete rescue of 
the pleiotropic array of btn1Δ phenotypes. This approach 
represents the most successful rescue of cellular dysfunc-
tion in any model for juvenile CLN3 disease to date. 
 
RESULTS 
Genome-wide analysis of genetic interactions with btn1 
reveals a central role for TOR kinases 
We applied an SGA approach as an unbiased, genome-wide 
strategy to probe the interactions of a conserved neuro-
degenerative disease gene (btn1). We identified 331 posi-
tive interactors and 131 negative interactors of btn1 (Table 
S1A and B). A large number of negative interactions (n = 
39; 29.7%) mapped to a set of highly interconnected signal-
ling processes, which center on the Tor kinase complexes 
TORC1 and TORC2 (Fig. 1). Core components of both com-
plexes display genetic interactions with btn1; tco89, encod-
ing a component of TORC1, was found to interact positively 
with btn1, while tor1, encoding the Tor kinase of TORC2, 
was found to interact negatively with btn1. Such a pattern 
suggests that TORC2 signalling is beneficial to the fitness of 
btn1Δ cells, whereas TORC1 signalling is detrimental, an 
observation that is in keeping with the idea that the two 
complexes play opposing roles and undergo mutual repres-
sion [22-24]. btn1 was also found to negatively interact 
with genes encoding components of the connected cell 
wall integrity (CWI) and stress-associated protein kinase 
(SAPK) MAP kinase cascades, and a number of down-
stream stress regulated genes (Table S1A and B). 
 
btn1Δ cells display features consistent with dysfunctional 
Tor signalling 
The interaction of btn1 with core TORC components, and 
the link to surrounding signalling processes, provides com-
pelling evidence for the importance of Tor signalling in cells 
lacking btn1. To validate this observation, we investigated 
btn1Δ cells for features consistent with Tor dysfunction. 
Repression of TORC1 activity is required to mount a correct 
response to nitrogen limitation [24]. As loss of TORC1 activ-
ity was beneficial in cells lacking btn1, we hypothesised 
that these cells may display features consistent with 
dysregulation of TORC1 repression, and respond poorly to 
nitrogen limitation. To test this idea, we grew wild-type 
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and btn1Δ cells in minimal media, and minimal media lack-
ing a nitrogen source, over 72 h. Viability was monitored at 
24 h intervals using propidium iodide to label dead cells 
and calcofluor white to label the total cell population (Fig. 
2A). Cells lacking btn1 displayed a consistently lower viabil-
ity in media lacking nitrogen, falling to 81.5 ± 2.2% after 24 
h compared to 98.7 ± 0.27% in minimal media containing 
nitrogen (P < 0.0015, unpaired t test), and remaining lower 
throughout the time course. Wild-type cells displayed no 
change in viability when cultured in media lacking nitrogen. 
TORC1 repression and TORC2 signalling is also required 
to mount a response to glucose limitation [25, 26]. Cells 
that are defective in TORC2 function do not respond ap-
propriately to glucose limitation by reducing their cell 
length [26]. This is a relatively uncommon phenotype, with 
only tor1 mutants and mutants in the Ca
2+
/calmodulin-
dependent-like gene ssp1 known to display this phenotype 
[26, 27]. To test the ability of btn1Δ cells to adapt to condi-
tions of limited glucose, we assessed both cell growth and 
the morphological response of these cells when grown 
with an alternative carbon source (glycerol). Cells lacking 
btn1 displayed a clear growth defect under these condi-
tions (Fig. 2B). Wild-type and btn1Δ cells grown for 6 h in 
media containing either glucose or glycerol as a carbon 
source were stained with calcofluor white to visualise the 
cell wall. Cell elongation was determined using a measure 
of cell circularity and given a score of between 0 and 1, 
where 0 represents a perfectly round cell (Fig. 2C and D). 
Wild-type cells displayed a significant reduction in cell 
elongation upon growth in glycerol (0.25 ± 0.01 to 0.16 ± 
0.01, P ≤ 0.01). Cells lacking btn1, however, displayed no 
significant change (0.32 ± 0.02 to 0.31 ± 0.02), consistent 
with a defect in their response to glucose limitation that is 
most likely linked to Tor1 function. 
Lastly, TORC2 and the connected CWI pathway are also 
required for resistance to high temperature [26]. This tem-
perature sensitivity of TORC2 and CWI pathway compo-
nents is osmoremedial, i.e. it can be rescued by hypertonic 
growth media [28]. We confirmed the temperature sensi-
tivity of btn1Δ cells, and that it can be rescued with 2M 
FIGURE 2: btn1Δ cells dis-
play features consistent 
with dysfunction in TOR 
signalling processes. (A) 
Cell viability upon nitrogen 
limitation was determined 
over periods of up to 72 
hours in wild-type (WT) and 
btn1Δ cells, using the cell 
impermeable nucleotide 
stain propidium iodide to 
stain dead cells and calco-
fluor white to stain the 
total cell population. Cells 
were cultured in either MM 
or MM lacking a nitrogen 
source (NH4Cl). 500 cells 
were scored for viability per 
data set, and data shown is 
a mean (± SEM) of 3 inde-
pendent experiments. (B) 
WT cells and btn1Δ cells 
were serially diluted from a 
log-phase culture (1 x 10
6
 
cells/ml), and spotted onto 
plates containing either 
glucose or glycerol as a 
carbon source. Plates were 
then incubated at 30°C for 
6 - 7 days to determine 
growth on fermentative 
and non-fermentative car-
bon sources. Images are representative of three independent experiments. (C) The morphological response of WT and btn1Δ cells to growth 
on glycerol was analysed following 6 hours in culture using a measure of cell elongation, on a scale of 0 to 1, where 0 represents a perfectly 
round cell	(1 − (
			

			
)). Data shown is a mean (± SEM) of 5 independent experiments. Statistical significance between each condition 
was determined using a one-way ANOVA with a Tukey’s multiple comparison post-test (** = P < 0.01).  (D) Representative images of exper-
iments as performed in (C) are shown. Scale bar represents 10 μm. (E) WT and btn1Δ cells were also serially diluted from a log-phase culture 
(1 x 10
6
 cells/ml) and spotted onto YES plates and YES plates containing 2M sorbitol. Plates were then incubated at 37°C for 3 - 4 days to 
determine the growth at high temperature and the influence of osmotic stabilisation. Images are representative of three independent ex-
periments. 
 
M.E. Bond et al. (2015)  TOR signalling in juvenile CLN3 disease 
 
 
OPEN ACCESS | www.microbialcell.com 470 Microbial Cell | December 2015 | Vol. 2 No. 12 
sorbitol (Fig. 2E), consistent with previous observations 
[16]. 
These data together indicate that cells lacking btn1 dis-
play many features consistent with defects in Tor signalling 
and function. Further, ectopic expression of btn1 was able 
to rescue all these aspects of the mutant phenotype (Fig. 
S1A - D). Combined with the SGA results, these results sug-
gest that Tor signalling is critical to the defects observed in  
FIGURE 3: Increasing 
TORC2-dependent signalling 
rescues aspects of btn1Δ 
phenotype. (A) Cells lacking 
btn1 were transformed with 
an expression vector con-
taining gad8. Vacuole size 
was measured in these cells, 
in addition to WT and btn1Δ 
cells containing empty vec-
tor, following staining with 
the vital dye FM4-64. The 
diameter of 300 vacuoles 
was determined per data 
set, and data shown is a 
mean (± SEM) of 4 inde-
pendent experiments. Sta-
tistical analysis was per-
formed using a one-way 
ANOVA with a Tukey’s mul-
tiple comparison post-test 
(** = P < 0.01, *** = P < 
0.001).  (B) Representative 
images of experiments as 
performed in (A) are shown. 
Scale bar represents 10 μm. 
(C) The morphological re-
sponse of these populations 
to growth on glycerol was 
analysed following 6 hours 
in culture using a measure 
of cell elongation, on a scale 
of 0 to 1, where 0 repre-
sents a perfectly round 
cell 	(1 − (
			

			
)). Data 
shown is a mean (± SEM) of 
5 independent experiments. 
Statistical significance be-
tween each condition was 
determined using a one-way 
ANOVA with a Tukey’s mul-
tiple comparison post-test 
(*** = P < 0.001). (D) Repre-
sentative images of experi-
ments as performed in (C) 
are shown. Scale bar repre-
sents 10 μm. (E) These cells 
were serially diluted from a 
log-phase culture (1 x 10
6
 
cells/ml) and spotted onto 
YES plates. Plates were then 
incubated at 30°C or 37°C 
for 3 - 4 days to determine 
growth at high temperature. 
They were also spotted onto plates containing either glucose or glycerol as a carbon source. Plates were then incubated at 30°C for 6 - 7 
days to determine growth under non-fermentative conditions. Images are representative of three independent experiments. (F) Viability 
upon nitrogen limitation was determined over periods of up to 72 hours in these cell populations, using propidium iodide to stain dead cells 
and calcofluor white to stain all cells. Cells were cultured in either MM or MM lacking a nitrogen source (NH4Cl). 500 cells were scored for 
viability per data set, and data shown is a mean (± SEM) of 3 independent experiments.  
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btn1Δ cells. 
 
TORC2 and CWI pathway: modulating distinct signalling 
nodes elicit different levels of correction in btn1Δ cells 
Given the negative genetic interaction between btn1 and 
tor1, increasing TORC2 activity could alleviate aspects of 
the btn1Δ phenotype. We initially explored this approach 
through overexpression of the downstream kinase Gad8, 
which is a multicopy suppressor of aspects of the loss of 
TORC2 [29]. A key phenotype in cells lacking btn1, and one 
that is strongly linked to the phenotype of CLN3 disease, is 
a change in vacuole homeostasis [12]. One of the clearest 
manifestations of this feature in btn1Δ cells is an increase 
in vacuole size [12]. We investigated vacuole size in wild-
type and btn1Δ cells containing empty vector alone (as a 
control), as well as btn1Δ cells expressing gad8 from the 
nmt1 promoter of the pREP41 plasmid (Fig. 3A and B). 
Consistent with previous reports, btn1Δ cells exhibited 
significantly larger vacuoles than wild-type cells (0.65 ± 
0.03 μm compared to 0.39 ± 0.01 μm, P ≤ 0.001). The over-
expression of gad8 in btn1Δ cells significantly rescued vac-
uole size (0.40 ± 0.03 μm) (P ≤ 0.01), restoring them to 
near that of wild-type. These data provide the first indica-
tion that increasing TORC2 function significantly rescues a 
disease-relevant phenotype of btn1Δ cells. 
As discussed above, the ability of cells to respond to 
glucose-limitation with a change in cell size requires TORC2 
function [26]. To investigate whether the inability of btn1Δ 
cells to undergo this morphological response can be res-
cued by increasing TORC2 pathway activity, we assessed 
the elongation of btn1Δ cells overexpressing gad8 follow-
ing growth for 6 hours in media containing either glucose 
or glycerol as a carbon source (Fig. 3C and D). Wild-type 
and btn1Δ cells containing empty vector alone displayed 
comparable responses to cells without vector (WT glucose 
- 0.28 ± 0.01, WT glycerol - 0.19 ± 0.01, P ≤ 0.001; btn1Δ 
glucose - 0.32 ± 0.02, btn1Δ glycerol - 0.28 ± 0.01, ns). The 
overexpression of gad8 was able to significantly rescue this 
morphological response, despite these cells being elongat-
ed under growth in glucose (glucose - 0.36 ± 0.01, glycerol - 
0.19 ± 0.01, P ≤ 0.001). 
Despite this rescue, expression of gad8 was unable to 
significantly rescue the growth of btn1Δ cells on glycerol or 
at high temperature, suggesting that the ability of these 
cells to adapt to heat and nutrient stress is still impaired 
(Fig. 3E). Similarly, expression of gad8 was unable to rescue 
the viability of btn1Δ cells grown in the absence of a nitro-
gen source (Fig. 3F). 
Given that the phenotypes not rescued by increasing 
TORC2 activity were linked to stress and nutrient adapta-
tion, we reasoned that modulating processes more closely 
linked to the CWI pathway might be more effective in cor-
recting these phenotypes. These processes seem particu-
larly relevant in this instance, as this pathway is known to 
respond to both heat and glucose limitation. In particular, 
mutants of the pmk1 MAP kinase, like btn1Δ mutants, dis-
play a partial growth defect on glycerol. Further, this path-
way is required for proper activation of Sty1 (the MAP ki-
nase of the SAPK pathway) under glucose-limitation, inte-
grating these processes with further identified btn1 in-
teractors [30].  
To increase CWI activity, we chose to increase Rho 
GTPase levels in these cells, which represent a key hub in 
CWI pathway regulation, by overexpressing the btn1 in-
teractor rho5 and its essential paralogue rho1. Overexpres-
sion of rho1 significantly decreased vacuole size in btn1Δ 
cells (P ≤ 0.001) to near that of wild-type cells containing 
empty vector alone (WT - 0.30 ± 0.02 μm, btn1Δ - 0.47 ± 
0.04 μm, btn1Δ with p41rho1 - 0.32 ± 0.01 μm) (Fig. 4A and 
B).  The overexpression of rho5 led to an over-correction of 
this phenotype (0.19 ± 0.01 μm), producing vacuoles signif-
icantly smaller than those of btn1Δ cells (P ≤ 0.001) and 
wild-type cells containing vector alone (P ≤ 0.05). Con-
sistent with these observations, over-expression of pmp1, 
which inhibits the activity of pmk1 [31], caused an increase 
in vacuole size in btn1Δ cells (btn1Δ with p41pmp1 - 0.80 ± 
0.08 μm vs btn1Δ - 0.52 ± 0.04 μm, P ≤ 0.01) but not in 
wild-type cells (WT with p41pmp1 – 0.24 ± 0.01 μm vs WT 
– 0.23 ± 0.02, ns) (Fig. 4C). Such data indicate that increas-
ing CWI pathway activity is able to correct the vacuole de-
fect of btn1Δ cells, and directly inhibiting this pathway ex-
acerbates the vacuole defect. The over-correction by rho5 
could indicate a strong dose-dependence in this particular 
rescue. Indeed, previous work has demonstrated such dose 
dependence in the relationship between btn1 and vacuole 
size [12]. 
We next investigated whether the Rho GTPases were 
able to rescue the morphological response of these cells to 
glycerol, as seen with gad8. We looked just at rho1 in this 
case, as rho5 overexpression has a pronounced effect on 
cell shape and septation [32], making morphological com-
parisons difficult (Fig. S2). Overexpression of rho1 elicited a 
rescue of this response, with cells displaying a significant 
reduction in cell elongation when grown in glycerol con-
taining media (0.28 ± 0.02 to 0.16 ± 0.01, P ≤ 0.01) (Fig. 4D 
and E). 
Further to a rescue of the morphological response to 
glycerol, both rho1 and rho5 were able to correct the 
growth defect of btn1Δ cells on glycerol as a carbon source. 
In addition, rho1 was able to rescue the temperature sensi-
tivity phenotype of these cells (Fig. 4F). The overexpression 
of rho5 did not correct this phenotype, although, given the 
link between heat-sensitivity and septation defects in 
btn1Δ cells [15] and the enhanced septation defect of cells 
overexpressing rho5 (Fig. S2), this is not wholly unexpected. 
In addition to these phenotypes, overexpression of 
rho1 and rho5 rescued the viability of btn1Δ cells when 
grown in the absence of a nitrogen source, with viability 
remaining higher than 95% throughout the course of the 
experiment (Fig. 4G). These data provide evidence for a 
profound positive interaction between CWI pathway sig-
nalling and btn1, indicating that such processes are inti-
mately linked with the defects that occur in btn1Δ cells. 
 
Reducing TORC1 activity corrects defects in btn1Δ cells 
TORC1 activity is a key signal of a favourable environment, 
promoting proliferation and  suppressing  stress-responsive  
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FIGURE 4: Overexpression of Rho rescues all aspects of 
btn1Δ phenotype. (A) Cells lacking btn1 were trans-
formed with an expression vector containing rho1 or rho5. 
Vacuole size was measured in these cells, in addition to 
wild-type (WT) and btn1Δ cells containing empty vector, 
following staining with the vital dye FM4-64. The diameter 
of 300 vacuoles was measured per data set, and data 
shown is a mean (±SEM) of 4 independent experiments. 
Statistical analysis was performed using a one-way ANO-
VA with a Tukey’s multiple comparison post-test (** = P < 
0.01, *** = P < 0.001).  (B) Representative images are 
shown in lower panels. Scale bar represents 10 μm. (C) 
WT and cells lacking btn1 were transformed with an ex-
pression vector containing pmp1. Vacuoles were stained 
and measured as for (A). Statistical analysis was per-
formed using a one-way ANOVA with a Tukey’s multiple 
comparison post-test (** = P < 0.01). (D) The morphologi-
cal response of WT and btn1Δ cells containing empty vec-
tor as well as btn1Δ cells overexpressing rho1 to growth 
on glycerol was analysed following 6 hours in culture us-
ing a measure of cell elongation, on a scale of 0 to 1, 
where 0 represents a perfectly round cell 	(1 −
(
			

			
)). Data shown is a mean (±SEM) of 5 independ-
ent experiments. Statistical significance between each 
condition was determined using a one-way ANOVA with a 
Tukey’s multiple comparison post-test (** = P < 0.01). (E) 
Representative images of experiments as performed in 
(D) are shown. Scale bar represents 10 μm. (F) Wild-type 
and btn1Δ cells containing empty vector as well as btn1Δ 
cells overexpressing rho1 and rho5 were serially diluted 
from a log-phase culture (1 x 10
6
 cells/ml) and spotted on-
to YES plates. Plates were then incubated at 30°C or 37°C 
for 3-4 days to determine growth at high temperature. 
They were also spotted onto plates containing either glu-
cose or glycerol as a carbon source. Plates were then in-
cubated at 30°C for 6-7 days to determine growth under 
non-fermentative conditions. Images are representative 
of three independent experiments. (G) Viability upon ni-
trogen limitation was determined over periods of up to 72  
hours in these cell populations, using propidium iodide to stain dead cells and calcofluor white to stain all cells. Cells were cultured in either 
MM or MM lacking a nitrogen source (NH4Cl). 500 cells were scored for viability per data set, and data shown is a mean (±SEM) of 3 inde-
pendent experiments. 
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processes [24]. As a consequence, it is antagonistic to 
many of the processes explored in this study that improved 
the btn1Δ phenotype. TORC1 represses TORC2 function 
[23], and negatively regulates Sty1 [33], which displays 
extensive cross-talk with the CWI pathway [30]. This rela-
tionship is highlighted by the fact that the core TORC1 
component gene tco89 is a positive interactor of btn1. 
In order to test whether repression of TORC1 activity 
could rescue the phenotypes of btn1Δ cells, we first over-
expressed a dominant-negative form of the upstream acti-
vator of TORC1, Rhb1 (rhb1
D60K
) [34]. Upon overexpression 
of dominant-negative rhb1 (dnrhb1) in btn1Δ cells, we ob-
served a significant reduction (P ≤ 0.001) in vacuole size 
compared to btn1Δ cells containing vector alone (btn1Δ 
with p41dnrhb1 - 0.40 ± 0.04 μm, btn1Δ with empty vector 
- 0.65 ± 0.03 μm) (Fig. 5A and B). This result was compara-
ble to the vacuole size of wild-type cells (0.39 ± 0.01 μm), 
indicating a rescue of vacuole morphology upon repression 
of TORC1 activity. 
We next investigated the ability of TORC1 repression to 
rescue the nutrient-sensing defects of cells lacking btn1. 
The overexpression of dnrhb1 led to a significant rescue of 
the morphological response of these cells to glucose-
limitation, following 6 hours growth in glycerol as a carbon 
source (Fig. 5C and D). Cell elongation fell from 0.29 ± 0.02 
to 0.18 ± 0.01 when grown in glycerol as opposed to glu-
cose, a response comparable to that observed in wild-type 
cells (glucose - 0.28 ± 0.01, glycerol - 0.19 ± 0.01). This also 
corresponded to a rescue of the growth defect of these 
cells on glycerol (Fig. 5E). Further to the glycerol growth 
FIGURE 5:  Inhibiting TORC1 function res-
cues the defects in btn1Δ cells. (A) Cells 
lacking btn1 were transformed with an ex-
pression vector containing a dominant-
negative form of rhb1 (dnrhb1). Vacuole size 
was measured in these cells, in addition to 
wild-type (WT) and btn1Δ cells containing 
empty vector, following staining with the 
vital dye FM4-64. The diameter of 300 vacu-
oles was measured per data set, and data 
shown is a mean (± SEM) of 4 independent 
experiments. Statistical analysis was per-
formed using a one-way ANOVA with a Tuk-
ey’s multiple comparison post-test (*** = P 
< 0.001).  (B) Representative images of ex-
periments as performed in (A) shown. Scale 
bar represents 10 μm. (C) The morphologi-
cal response of these populations to growth 
on glycerol was analysed following 6 hours 
in culture using a measure of cell elonga-
tion, on a scale of 0 to 1, where 0 represents 
a perfectly round cell 	(1 − (
			

			
)). 
Data shown is a mean (± SEM) of 5 inde-
pendent experiments. Statistical significance 
between each condition was determined 
using a one-way ANOVA with a Tukey’s 
multiple comparison post-test (*** = P < 
0.001).  (D) Representative images of exper-
iments as performed in (C) shown. Scale bar 
represents 10 μm. (E) These cells were seri-
ally diluted from a log-phase culture (1 x 10
6
 
cells/ml) and spotted onto YES plates. Plates 
were then incubated at 30°C or 37°C for 3-4 
days to determine growth at high tempera-
ture. They were also spotted onto plates 
containing either glucose or glycerol as a 
carbon source. Plates were then incubated 
at 30°C for 6-7 days to determine growth 
under non-fermentative conditions. Images 
are representative of three independent 
experiments. (F) Viability upon nitrogen 
limitation was determined over periods of 
up to 72 hours in these cell populations, 
using propidium iodide to stain dead cells and calcofluor white to stain all cells. Cells were cultured in either MM or MM lacking a nitrogen 
source (NH4Cl). 500 cells were scored for viability per data set, and data shown is a mean (± SEM) of 3 independent experiments. Scale bar 
represents 10 μm. 
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defect, dnrhb1 overexpression also rescued the heat sensi-
tivity of btn1Δ cells (Fig. 5E). Finally, this construct was also 
able to elicit a complete rescue of viability under nitrogen 
limiting conditions, with viability remaining above 95% 
throughout the course of the experiment (Fig. 5F). 
Given the substantial rescue of btn1Δ cells by dnrhb1-
mediated activation of TORC1, we wanted to confirm the 
interaction between btn1 and TORC1 by another means. 
We chose to use two pharmacological inhibitors of TORC1, 
rapamycin (allosteric) and caffeine (competitive inhibitor of 
ATP binding) [35]. TORC1 antagonism leads to cell rounding, 
a response that mimics the morphological change ordinari-
ly exhibited by wild-type cells in response to nitrogen and 
amino acid starvation. Therefore, we examined the effect 
of TORC1 antagonism on cell rounding [36] and on vacuole 
size, heat sensitivity, and growth in glycerol. As expected, 
wild-type cells displayed a significant reduction in cell 
elongation upon rapamycin treatment for 6 hours (0.26 ± 
0.02 to 0.15 ± 0.01, P ≤ 0.01) (Fig. 6A and B). This reduction 
in cell elongation did not change further upon exposure to 
both rapamycin and caffeine [35]. Cells lacking btn1, how-
ever, did not respond to rapamycin, displaying only a slight 
morphological change (0.30 ± 0.01 to 0.25 ± 0.02) that was 
slightly enhanced by the addition of caffeine and rapamy-
cin, but again not significantly (0.22 ± 0.03) (Fig. 6A and B). 
The addition of caffeine and rapamycin to wild-type cells 
did not significantly affect vacuole size (vehicle - 0.37 ± 
0.05 μm, rapamycin - 0.31 ± 0.03, caffeine and rapamycin 
0.24 ± 0.01) (Fig. 6C and D). Rapamycin alone had no effect 
on the vacuole size of cells lacking btn1, but, in contrast, a 
combination of caffeine and rapamycin significantly (P ≤ 
0.001) reduced vacuole size (vehicle - 0.58 ± 0.03 μm, ra-
pamycin - 0.55 ± 0.04, caffeine and rapamycin 0.30 ± 0.02) 
(Fig. 6C and D). Further, treatment with rapamycin alone 
elicited a rescue of both the heat sensitivity defect and 
glycerol growth defect of cells lacking btn1 (Fig. 6E). The 
ability of these pharmacological treatments to rescue the 
defects in vacuole size, heat sensitivity and growth in glyc-
erol of btn1Δ cells appears to be closely linked to their abil-
ity to target TORC1 signalling itself, as opposed to changes 
FIGURE 6: Pharmacological inhibition of 
TORC1 function replicates rescue by 
overexpression of dominant-negative 
rhb1. (A) The morphological response of 
wild-type (WT) and btn1Δ cells to the 
TORC1 antagonists rapamycin (100 μg/ml) 
and caffeine and rapamycin combined (10 
mM and 100 μg/ml respectively) was 
analysed following 6 hours in culture 
using a measure of cell elongation, on a 
scale of 0 to 1, where 0 represents a per-
fectly round cell	(1 − (
			

			
)). Data 
shown is a mean (± SEM) of 6 independ-
ent experiments. Statistical significance 
between each condition was determined 
using a one-way ANOVA with a Tukey’s 
multiple comparison post-test (** = P < 
0.01).  (B) Representative images of ex-
periments as performed in (A) are shown. 
Scale bar represents 10 μm. (C) Wild-type 
and btn1Δ cells were grown for 6 hours in 
MM alone or with the TORC1 antagonists 
rapamycin (100 μg/ml) and caffeine and 
rapamycin (10 mM and 100 μg/ml respec-
tively). Vacuole size was then measured in 
these cells following staining with the vital 
dye FM4-64. The diameter of 300 vacu-
oles was measured per data set, and data 
shown is a mean (± SEM) of 4 independ-
ent experiments. Statistical analysis was 
performed using a one-way ANOVA with a 
Tukey’s multiple comparison post-test 
(*** = P < 0.001). (D) Representative im-
ages of experiments as performed in (C) 
are shown. Scale bar represents 10 μm. 
(E) WT and btn1Δ cells were serially dilut-
ed from a log-phase culture (1 x 10
6
 
cells/ml) and spotted onto YES plates either containing or lacking rapamycin (100 μg/ml). Plates were then incubated at 37°C for 3-4 days to 
determine growth at high temperature. They were also spotted onto plates containing glycerol as a carbon source either containing or lack-
ing rapamycin (100 μg/ml). Plates were then incubated at 30°C for 6-7 days to determine growth under non-fermentative conditions. Images 
are representative of three independent experiments. 
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in the activity of the connected SAPK pathway, as expres-
sion of a constitutively active wis1 mutant (wis1DD) [37] 
did not rescue these phenotypes (Fig S3A - C). These data 
confirm that activation of the TORC1 pathway pharmaco-
logically in btn1Δ cells rescues most of the phenotypes 
arising from loss of btn1 function. However, the pharmaco-
logical inhibition of the TORC1 pathway is not completely 
equivalent to the inhibition of the TORC1 pathway using 
dnrhb1 in btn1Δ cells. 
 
DISCUSSION 
In this study, SGA analysis was used as an unbiased ap-
proach to identify the genetic interactors of btn1, and 
place btn1 into its biological context within the whole cell. 
This approach highlighted a key role for the Tor kinase 
complexes, TORC1 and TORC2, in the dysfunctional chang-
es that occur in fission yeast lacking btn1, as one third of 
the interactions connected directly with pathways in which 
these complexes are active. Further, we have shown that 
btn1Δ cells display defects in their stress response to nitro-
gen and glucose limitation, in addition to osmoremedial 
heat sensitivity, consistent with TORC1 and TORC2 dys-
function in these cells (Fig. 7).  
Specifically, the SGA identified negative interactions in 
tor1, the core kinase component of TORC2, multiple com-
ponents of the stress-activated protein kinase (SAPK) 
pathway, and a component of the linked CWI pathway. In 
addition, tco89, encoding a core component of TORC1, 
which antagonises both the SAPK cascade and TORC2 sig-
nalling, was identified as a positive genetic interactor of 
btn1. btn1 was also found to interact negatively with a 
number of genes that display stress-responsive expression. 
TORC1 negatively regulates a number of processes as-
sociated with cellular catabolism and adaptation to stress 
[24]. One of these roles is in the repression of autophagy. 
Autophagy similarly appears important to the fitness of 
btn1Δ cells, as atg14 and atg12 were identified as negative 
interactors of btn1, and both are required for autophago-
some formation [38]. In support of this work, and the use 
of yeast as a model, defective autophagy has previously 
been linked to CLN3 disease [39]. In repressing stress-
responsive processes, TORC1 is known to negatively regu-
late sty1, the mitogen-activated protein (MAP) kinase and 
component of the stress-activated protein kinase (SAPK) 
cascade [33]. Both wis4 and wis1, encoding the MAP kinase 
kinase kinase and MAP kinase kinase of the SAPK pathway, 
FIGURE 7: Diagrammatic summary of the effect of loss of btn1 on the response to stress. The left panel shows the response of healthy 
cells to stresses applied in this study, such as low nitrogen or glucose or raised temperature. These cells are able to respond via intercon-
nected signaling pathways such as CWI, TORC and SAPK. Activation of these pathways allows the cell to respond to the effects of stress and 
restore cell homeostasis and integrity. In contrast, cells lacking btn1 are unable to respond to the applied stresses (represented by ‘?’ and 
‘X’) and undergo a variety of previously reported responses that include an increase in vacuole size, swollen and disorganized Golgi and mis-
trafficking of vacuole enzymes such as carboxypeptidase Y, increased septation index and longer cell cycle and cell length, monopolar 
growth, defective cell wall, absence of cell rounding (in response to low glucose). Genetic or pharmacological activation of the three signal-
ling pathway provides partial or full rescue of these pleiotropic phenotypes of btn1Δ cells. G, Golgi; Sec, secretory vesicles; V, vacuole; SI, 
division septum; M, monopolar growth. 
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respectively, interact negatively with btn1, as does the 
transcription factor gene pap1, which is a downstream 
target of sty1 [40]. Furthermore, btn1 interacts negatively 
with a number of genes that display stress-responsive ex-
pression. 
TORC2 is a positive regulator of stress-responsive pro-
cesses [29], and is also involved in cytoskeletal organization, 
vacuolar morphology and glucose sensing [22]. In addition 
to a negative interaction with the gene encoding the Tor 
kinase component of TORC2 (tor1), btn1 also negatively 
interacts with genes encoding components of the connect-
ed CWI MAP kinase cascade. The relationship between 
TORC2 and the CWI pathway is complex. TORC2 is required 
for the response to cell wall stressors [41], and is a direct 
regulator of the CWI pathway through the activation of the 
Rho guanine-nucleotide exchange factor (GEF) ROM2 in 
budding yeast [42]. In fission yeast, it has recently been 
shown that Tor1, acting as part of TORC2, enhances Pck2 
synthesis to activate the CWI under both cell wall stress 
and glucose limitation conditions [43].  
Despite this positive relationship, recent work in fission 
yeast has indicated a negative regulation of TORC2 by 
pmk1, the MAP kinase component of the fission yeast CWI 
pathway, at least in certain conditions [25]. In fission yeast 
both Rho1 and Rho2 are well established as regulators of 
the CWI pathway [44, 45]. Rho5 acts as a functional 
homologue of rho1, sharing the role of regulating cell wall 
homeostasis [46]. More recently, rho5 has also been 
shown to be an upstream regulator of the CWI [47]. The 
regulation of this pathway is complex as Rho1 both posi-
tively [45] and negatively [48] regulates the downstream 
MAP kinase cascade. This potentially intricate relationship 
is reflected in the interactors of btn1 that fall within this 
pathway, that exhibit both positive and negative effects 
upon signalling. btn1 exhibits a negative interaction with 
the rho1 homologue gene rho5, and a number of genes 
involved in downstream cytoskeletal and polarity compo-
nents. Despite this, the Rho GEF gene rgf1, which is a posi-
tive regulator of the CWI pathway [49], is a positive in-
teractor of btn1 whereas rdi1 (encoding a GDP dissociation 
factor) is a negative interactor. This multifaceted pattern of 
interactions is consistent with current understanding of 
this pathway, given the complex interactions between 
these signalling nodes. 
Although a process that maintains CWI might seem 
fungal-specific, and not relevant to disease in a higher eu-
karyote, previous work in budding yeast revealed similar 
dysfunctional processes in cells overexpressing α-synuclein 
as a model for Parkinson’s disease, suggesting that there is 
a mammalian counterpart to the CWI pathway in yeast. 
Such observations are of specific relevance to CLN3 disease, 
as α-synuclein is also upregulated in this condition [9]. 
RHO1 signalling and the CWI pathway are disrupted by 
overexpression of α-synuclein [50]. Further, it was demon-
strated that similar changes in downstream kinase cas-
cades could be observed in mammalian cells overexpress-
ing α-synuclein. Affected kinases included c-Jun, which has 
previously been linked to CLN3 disease, and is part of a 
pathway closely related to the SAPK pathway in yeast [51]. 
This is not the only instance in which Rho signalling has 
been linked to neurodegeneration. Leucine-rich repeat 
kinase 2 (LRRK2), mutations in which represent the most 
common cause of familial late-onset Parkinson’s disease, 
has been shown to bind Rac1, and to a lesser extent RhoA 
and Cdc42 [52]. All of these binding partners are members 
of the Rho GTPase family. The binding of LRRK2 to Rac1 led 
to its activation and relocalisation, and was lost when dis-
ease-causing mutations were introduced into LRRK2. Fur-
ther, the overexpression of Rac1 was shown to be protec-
tive in these cells. Other studies have also demonstrated a 
protective effect of Rho signalling, focusing both on Rho 
GEFs [53] and the Rho GTPases themselves [54]. Such stud-
ies highlight how processes as seemingly specialized as CWI 
in yeast can be highly informative of processes relevant to 
disease in higher order eukaryotes. Further, they demon-
strate that Rho-dependent signalling could be a vital neu-
roprotective process in more common neurodegenerative 
disease, as well as being a key pathway in the neurodegen-
erative disease model presented in this study. 
Importantly, the validation of these interactions during 
this work revealed interventions that produced a complete 
rescue of all phenotypes investigated in the btn1Δ strain, 
including phenotypes linked to TORC1 function, TORC2 
function, CWI and vacuole homeostasis. Among the inter-
actions investigated, increasing Rho1 levels, and thereby 
upregulating the main signalling node in the CWI pathway, 
or repressing TORC1 function (pharmacologically or genet-
ically) led to complete rescues.  
More notably, a neuroprotective role of TORC1 repres-
sion is already well established in a number of different 
systems [55]. A protective effect of the TORC1 antagonist 
rapamycin has been demonstrated in models for Parkin-
son’s disease [57], Huntington’s disease [56], spinoceribel-
lar ataxia type 3 [58] and retinal degeneration mediated by 
mitochondrial dysfunction [59]. In addition, Tor signalling is 
also elevated in Alzheimer’s disease models [60].  
It is important to note, however, that targeting TORC1 
in disease presents some technical challenges. Although in 
some studies an increase in lysosome function has been 
observed upon rapamycin treatment [61], other work indi-
cates that rapamycin is an incomplete antagonist of TORC1 
and a poor inducer of lysosomal functions [62], in concert 
with our observations. Another complication of targeting 
TORC1 in disease is the antagonistic role of TORC2. TORC2 
signalling and the connected CWI pathway were both pro-
tective in our model for CLN3 disease. Further to the pro-
tective role of Rho signalling in a Parkinson’s disease model 
[50], TORC2/AKT signalling has also been shown to be neu-
roprotective in a separate study of Parkinson’s disease [63]. 
As a result, general Tor antagonists, such as Torin1, which 
target both TORC1 and TORC2, do not produce the same 
positive outcomes that TORC1 specific antagonists are able 
to elicit [57]. In addition, chronic rapamycin exposure also 
leads to a reduction in TORC2 activity. This fact could ex-
plain why rapamycin has been shown to be detrimental in 
certain studies, for example in one study using a fruit fly 
model for Alzheimer’s disease [64]. 
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Conclusion 
The data presented here highlight a set of interconnected 
pathways that, when modulated correctly, produce a pro-
found rescue of the dysfunctional changes observed in a 
yeast model for neurodegeneration caused by mutations in 
a single gene (Fig. 7). Links between CLN3 and the response 
to stress have previously been reported in other model 
organisms [51, 65], supporting the relevance of this yeast 
work to human CLN3 disease. Importantly however, a link 
between CLN3 and Tor signalling specifically, as reported 
here, is a novel mechanistic and therapeutic insight into 
CLN3 disease, the most common paediatric neurodegener-
ative disease. Furthermore, the pathways identified display 
strong parallels with known protective pathways in more 
common dementias, providing not only strong biological 
plausibility for the importance of these interactions, but 
also an indication that common processes may be exploit-
ed in therapeutic development for seemingly disparate 
neurodegenerative diseases. 
 
MATERIALS AND METHODS 
Yeast strains and cell growth 
The strains used in this study were the wild-type strains SP23 
(h–, ura4-D18, leu1-32, ade6-M210) and SP38 (h–, ura4-D18, 
leu1-32, ade6-210, his-) and btn1Δ strains SP29 (h-, 
btn1::NatMX, ura4-D18, leu1-32, ade6-210,) and SP35 (h-, 
btn1::NatMX, ura4-D18, leu1-32, ade6-210, his-). SP29 and 
SP35 were generated using the long primer method described 
in [66], using pFA6a-NatMX as a template [67]. Both strain 
backgrounds were used for SGA analysis (two isolates of each) 
to account for strain background differences, and SP23 and 
SP29 were used in all other analyses. Cell growth and manipu-
lations were performed as described previously [68]. Minimal 
media (MM) was used in all experiments, unless otherwise 
stated. In nitrogen starvation experiments NH4Cl was omitted. 
Glucose and glycerol media were made as described previous-
ly [69]. Appropriate supplements were added to the media as 
required. All assays were performed using log-phase cultures 
(1 x 10
6
 cells/ml). The dnrhb1 construct (pREP4X-rhb1
D60K
) was 
obtained from Dr. Elizabeth Henske [34], and the gad8 con-
struct (pREP41-gad8) from Dr. Ronit Weisman [70]. pREP1-
rho5 was obtained from Dr. Kentaro Nakano [46], pREP41-
rho1 from Dr. Pilar Pérez [48] and pREP1-wis1DD-3HA6His 
from Dr. Kaz Shiozaki [71]. The GFP-btn1 construct used in this 
study was described previously (pREP41-GFP-btn1) [12]. SP23 
containing empty vector (pREP41) was used as a control in all 
experiments using these constructs. 
 
Synthetic genetic arrays (SGAs) 
SGA analysis was performed as described in [20], using a Sing-
er RoToR robot (S. pombe settings) and the Bioneer haploid 
library (v2.0) and analysed as described previously [72]. A 
control SGA using ade6::NatMX4 as a query was performed 
simultaneously. The ade6Δ mutant does not alter the fitness 
of the deletion collection, and arising double mutants are used 
to determine Bioneer strain fitness and for colony size normal-
isation. After germination, haploid double mutants were 
pinned to YES + G418 + Nat in a 1536 format. After three days 
growth at 30°C, agar plates were imaged using a MultiDoc-It 
Imaging System (UVP) and processed for analysis using the 
Gitter image analysis R package [73]. Using Excel, the colony 
sizes produced by Gitter were normalized to the median colo-
ny size of each plate to account for within-plate positional 
growth effects and differential plate growth. These normalized 
values were used to establish the ratio of query btn1Δ mutant 
size to control (ade6:NatMX4) colony size. Ratios from the 
four btn1Δ isolates used for the screen were used to calculate 
a mean ratio. Using this mean value, colony-size ratio scores 
of < 0.8 were defined as negative interactions, and ratios of > 
1.2 as positive interactions. Genetic interactions were scored 
from two independent biological experiments. Only interac-
tions common to both replicates were considered robust 
enough for follow-up. Negative and positive interaction sets 
were tested using PANTHER [74]. 
 
Microscopy 
All images were obtained using a Leica SPE2 true scanning 
confocal microscope with 63 x 1.4 NA oil immersion objective. 
Images were recorded using Leica AF software. Calcofluor-
white (Sigma-Aldrich) staining was performed as described 
previously [68]. Calcofluor-white was used to allow cell seg-
mentation for assays of cell morphology. For assays of cell 
viability, propidium iodide (Sigma-Aldrich) was added to the 
cells (15 μg/ml final concentration) at the same point as the 
calcofluor-white. Staining was performed in a volume of 1 ml, 
allowed to proceed at room temperature for 10 min, and the 
cells were washed twice in MM before visualisation. No cell 
fixation was applied. The vital dye FM4-64 (Molecular Probes) 
was used to visualise vacuolar morphology. The staining pro-
cedure has been described previously [12]. 
 
Image analysis 
All microscopy image analysis was performed using ImageJ 
software. For analysis of cell morphology, cells were segment-
ed using the BOA plugin of the quantitative imaging of mem-
brane proteins (Quimp) package [75]. Cell elongation was then 
determined using the equation: 1 − (
			

			
). Thirty cells 
were counted per dataset.   
 
Statistical analysis 
All statistical analysis was performed using Prism software, 
version 6.0C (Graphpad). In instances where only two samples 
were compared, significance was determined using an un-
paired t test. In instances where multiple columns were com-
pared, an ordinary one-way ANOVA was used with a Tukey’s 
multiple-comparison post-test. All error bars represent mean 
± standard error of the mean (SEM). In all cases, the statistical 
test used, p-values and the number of samples analysed are 
highlighted in the figure legend for clarity. 
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